Millennium Management’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-17,500
| Closed | -$106K | – | 4878 |
|
|
2019
Q4 | $106K | Buy |
+17,500
| New | +$101K | ﹤0.01% | 4022 |
|
|
2019
Q1 | – | Sell |
-500,000
| Closed | -$795K | – | 4502 |
|
|
2018
Q4 | $795K | Buy |
+500,000
| New | +$1.41M | ﹤0.01% | 2697 |
|
|
2018
Q2 | – | Sell |
-500,000
| Closed | -$1.85M | – | 4378 |
|
|
2018
Q1 | $1.85M | Buy |
+500,000
| New | +$1.64M | ﹤0.01% | 2363 |
|
|
2016
Q4 | – | Sell |
-50,000
| Closed | -$405K | – | 3904 |
|
|
2016
Q3 | $405K | Buy |
+50,000
| New | +$425K | ﹤0.01% | 2694 |
|
|
2016
Q2 | – | Sell |
-400,000
| Closed | -$3.09M | – | 3780 |
|
|
2016
Q1 | $3.09M | Buy |
400,000
+200,000
| +100% | +$1.46M | 0.01% | 1549 |
|
|
2015
Q4 | $2.16M | Buy |
+200,000
| New | +$1.82M | ﹤0.01% | 1874 |
|
|
2015
Q2 | – | Sell |
-750,000
| Closed | -$7.39M | – | 4052 |
|
|
2015
Q1 | $7.39M | Buy |
750,000
+500,000
| +200% | +$6.24M | 0.01% | 1206 |
|
|
2014
Q4 | $3.06M | Sell |
250,000
-2,050,000
| -89% | -$25M | 0.01% | 1685 |
|
|
2014
Q3 | $23M | Buy |
+2,300,000
| New | +$21.3M | 0.06% | 446 |
|
Millennium Management's ACHN Position: Q1 2020 in Review
Millennium Management sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 548,616 shares — an estimated $3.31M sold.
Millennium Management first reported a position in ACHN in Q2 2013 and held it in 26 quarters. The position peaked at $52.7M in Q4 2015. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.
- Millennium Management reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
- Millennium Management sold 548,616 Achillion Pharmaceuticals shares in Q1 2020, an estimated $3.31M.
- Millennium Management first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 26 quarters.
- Millennium Management's Achillion Pharmaceuticals position peaked at $52.7M in Q4 2015.
- 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.
Based on Millennium Management's 13F filing for Q1 2020, filed 14 May 2020.